Home >Products> Reagents >Antibody> TOXO IgG Test
Reagents:  Molecular Biology   Biochemistry   Cell Biology   ELISA / Diagnostic Kits   Antibody   Serum/Medium   Other Reagents  
TOXO IgG Test
TOXO IgG Test
Place of Origin:
China
Brand:
Orient Gene
Model:
Infectious Disease
Price:
Hits:
405 
Updated:
4/20/2025
  • Product Detail
  • Company Profile
    Toxo Rapid Test Cassette is a lateral flow immunochromatographic assay for the rapid, qualitative and differential detection of IgG and IgM antibodies to Toxoplasma gondii in human whole blood, serum or plasma. Toxoplasmosis is a food borne illness caused by Toxoplasma gondii, a protist Pathogen. The ubiquitous intracellular living parasite is spread worldwide. Typical for sporocytes is the “flip-flop” between sexual (which only takes place in cats, the final host) and asexual reproduction. The Infection is often highest in areas of the world that have hot, humid climates and lower altitudes. The mean source of infection is direct contact with cat feces or from eating undercooked meats. Toxoplasmosis is not passed from person-to-person, except in instances of mother-to-child (congenital) transmission and blood transfusion or organ transplantation. Toxoplasmosis generally presents with mild symptoms in immunocompetent individuals, but women newly infected with Toxoplasma during pregnancy and anyone with a compromised immune system should be aware that toxoplasmosis can have severe consequences for them. Acute toxoplasmosis in pregnant women can result in miscarriage, poor growth, early delivery or stillbirth. IgG and IgM antibodies to Toxoplasma can be detected within 2-3 weeks after exposure. IgG remains positive, but the antibody level drops overtime.
    bio-equip.cn
    Zhejiang Orient Gene Biotech Co., Ltd specializes in the R&D, production, and sales of in vitro diagnostic products in the field of high-end medical equipment and devices.
    Currently, its main products are POCT instant diagnostic reagents, which are mainly used in the detection of infectious diseases (including COVID-19 detection products), drugs of abuse, fertility, tumor marker and cardiac marker detection, among which infectious disease and drugs of abuse detection are the two core product series of the company.
    The company’s sales network has been extended to more than 120 countries and regions, and its overseas sales revenue accounted for 95% in 2019. At present, the company has obtained more than 300 overseas certifications/records, and more than 70 domestic registration/record certificates.
Request Information
Request Information: yes no
Request Quotation: yes no
refresh

I agree to share my inquiry with the other matching suppliers.

Request Information

* Name:
Job Title:
* Tel:
Fax:
* E-mail:
Postcode:
Institution/Company:
Address:
* Country:
Request Information:
yes no
Request Quotation:
yes no
* Message:
* Verification Code:
refresh
I agree to share my inquiry to the other matching suppliers.